Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |